Skip to content
The Nexus
DossierENTITY

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Coverage of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration in the Nexus archive.

Earliest in view: Jul 16 · 11:00 UTCMost recent: Jul 16 · 11:00 UTC
Co-mentioned in this coverage
Dr. Jinsy A. Andrewsperson1NYU Langone’s ALS Centerorganization1Ozempictopic1Wegovytopic1GLP-1 agoniststopic1ALStopic1semaglutidetopic1
Recent coverage
  • HEALTHJul 16 · 11:00 UTCFOX NEWS
    Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders

    Neurologists warn that GLP-1 agonists like Ozempic and Wegovy, which promote rapid weight loss, may worsen neurodegenerative conditions such as ALS by accelerating physical decline. A case report shows an ALS patient’s condition deteriorated after using semaglutide, stabilizing only after discontinuation.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · Dossier · The Nexus